Henogen Report issue

For profit Phase 2 Phase 3
Founded: Charleroi Belgium (1999)
Status: Acquired by Novasep (2009)

Organization Overview

First Clinical Trial
2006
NCT00291941
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree